CN114276285A - Carotenoid preparation, and preparation method and application thereof - Google Patents
Carotenoid preparation, and preparation method and application thereof Download PDFInfo
- Publication number
- CN114276285A CN114276285A CN202111633948.7A CN202111633948A CN114276285A CN 114276285 A CN114276285 A CN 114276285A CN 202111633948 A CN202111633948 A CN 202111633948A CN 114276285 A CN114276285 A CN 114276285A
- Authority
- CN
- China
- Prior art keywords
- carotenoid
- preparation
- wall material
- pretreated
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021466 carotenoid Nutrition 0.000 title claims abstract description 67
- 150000001747 carotenoids Chemical class 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 239000000047 product Substances 0.000 claims abstract description 53
- 239000000463 material Substances 0.000 claims abstract description 40
- 239000000049 pigment Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 25
- 238000004090 dissolution Methods 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 239000007787 solid Substances 0.000 claims abstract description 17
- 229920002472 Starch Polymers 0.000 claims abstract description 11
- 235000013361 beverage Nutrition 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 11
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 11
- 239000008107 starch Substances 0.000 claims abstract description 11
- 235000019698 starch Nutrition 0.000 claims abstract description 11
- 235000010980 cellulose Nutrition 0.000 claims abstract description 10
- 229920002678 cellulose Polymers 0.000 claims abstract description 10
- 239000001913 cellulose Substances 0.000 claims abstract description 10
- 238000001879 gelation Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 235000009508 confectionery Nutrition 0.000 claims abstract description 5
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 4
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 4
- 235000015097 nutrients Nutrition 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 3
- 239000012467 final product Substances 0.000 claims abstract description 3
- 235000013305 food Nutrition 0.000 claims abstract description 3
- 229940095686 granule product Drugs 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 230000000007 visual effect Effects 0.000 claims abstract 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 239000013078 crystal Substances 0.000 claims description 41
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 34
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 33
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 27
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 27
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 27
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 27
- 239000001775 zeaxanthin Substances 0.000 claims description 27
- 235000010930 zeaxanthin Nutrition 0.000 claims description 27
- 229940043269 zeaxanthin Drugs 0.000 claims description 27
- 229930006000 Sucrose Natural products 0.000 claims description 24
- -1 fatty acid esters Chemical class 0.000 claims description 24
- 239000005720 sucrose Substances 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 239000000194 fatty acid Substances 0.000 claims description 22
- 229930195729 fatty acid Natural products 0.000 claims description 22
- 229960005375 lutein Drugs 0.000 claims description 22
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 20
- 235000010323 ascorbic acid Nutrition 0.000 claims description 17
- 239000011668 ascorbic acid Substances 0.000 claims description 17
- 239000001656 lutein Substances 0.000 claims description 17
- 235000012680 lutein Nutrition 0.000 claims description 17
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 15
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 15
- 229960005070 ascorbic acid Drugs 0.000 claims description 15
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 15
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 235000006708 antioxidants Nutrition 0.000 claims description 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 11
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 238000010008 shearing Methods 0.000 claims description 10
- 230000003078 antioxidant effect Effects 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 235000013734 beta-carotene Nutrition 0.000 claims description 7
- 239000011648 beta-carotene Substances 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 239000003889 eye drop Substances 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 7
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- 229940012356 eye drops Drugs 0.000 claims description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 claims description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229960003943 hypromellose Drugs 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 claims description 2
- FUWLWBDNQPTINE-UHFFFAOYSA-N 3-tert-butyl-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(C(C)(C)C)=CC2=C1 FUWLWBDNQPTINE-UHFFFAOYSA-N 0.000 claims description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000003903 alpha-carotene Nutrition 0.000 claims description 2
- 239000011795 alpha-carotene Substances 0.000 claims description 2
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims description 2
- 239000001168 astaxanthin Substances 0.000 claims description 2
- 235000013793 astaxanthin Nutrition 0.000 claims description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 2
- 229940022405 astaxanthin Drugs 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 2
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 10
- 230000004071 biological effect Effects 0.000 abstract description 4
- 238000004945 emulsification Methods 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 10
- 108010010803 Gelatin Proteins 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 8
- 239000008273 gelatin Substances 0.000 description 8
- 229920000159 gelatin Polymers 0.000 description 8
- 235000019322 gelatine Nutrition 0.000 description 8
- 235000011852 gelatine desserts Nutrition 0.000 description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 8
- 229940032147 starch Drugs 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 235000008210 xanthophylls Nutrition 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- JKQXZKUSFCKOGQ-YOPUJPICSA-N meso-zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@H](O)CC1(C)C JKQXZKUSFCKOGQ-YOPUJPICSA-N 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 125000000185 sucrose group Chemical group 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- XDLYMKFUPYZCMA-UHFFFAOYSA-M sodium;4-oct-1-enoxy-4-oxobutanoate Chemical compound [Na+].CCCCCCC=COC(=O)CCC([O-])=O XDLYMKFUPYZCMA-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000365 steroidogenetic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a carotenoid preparation, a preparation method and application thereof, wherein the preparation is prepared by mixing pretreated carotenoid and pretreated gelation wall material, and obtaining a powder or granule product through emulsification treatment and granulation; the dosage of the gelation wall material is 60-80% of the final product weight of the carotenoid preparation; the raw material of the pretreated gelation wall material comprises wall material and carbohydrate which are mixed according to the weight ratio of 1: 1-5; the wall material is selected from at least two of starch, Arabic gum and cellulose derivatives; the product produced by the method has a pigment dissolution rate of less than 1% in water, and can effectively maintain biological activity. Can be widely applied to the fields of food, beverage, health care products, medicine and the like, and particularly has good application prospect in the fields of preparing soft sweets, solid beverages, liquid beverages and the like which require the visual effect of nutrients.
Description
Technical Field
The invention relates to the technical field of particle preparation, and particularly relates to a carotenoid preparation, and a preparation method and application thereof.
Background
Carotenoids (carotenoids) are yellow, orange-red or red polyenes, generally composed of 8 isoprenoid units, of the formula C40H56. Carotenoids are known to have beneficial effects on health, and are physiological antioxidants that block lipid peroxidation and thus protect the follicular and uterine steroidogenic cells from oxidation. The carotenoid is provitamin A, and has effects of preventing nyctalopia, resisting oxidation, preventing cancer, and improving tinting strength. However, carotenoids are insoluble in water, have low solubility in fats and oils, and are unstable to light, oxygen, and heat, thereby limiting their applications. Conventional methods improve the bioavailability and also the coloring power of encapsulated products formed by microencapsulation of carotenoids, for example, some beautiful cakes and beverages are derived from carotenoids.
Meanwhile, the improvement of the coloring capability brings troubles, for example, the product is easily dyed on hands, clothes and even faces, and after the carotenoid product is taken, the surface of the tongue and a cup are also dyed, so that a bad experience is brought to people. None of the methods can maintain the biological activity of the carotenoid, reduce the dyeing ability of the carotenoid, and the like, so that the carotenoid can be better used by people, and is a problem which is considered by researchers in the field. A common solution to this problem is to crosslink the gelatin or protein to give crosslinked beads.
For example, patent GB993138 discloses a method for stabilizing gelatin-containing vitamin products, in which formaldehyde, glutaraldehyde, or the like is used as a crosslinking agent, and heat treatment is performed.
Patent CN1283454A, provides a method for preparing beads of fat-soluble substances by crosslinking gelatin using radiation or glutaminase, followed by spray drying into starchy powder.
Patent CN1764439A, provides a method for preparing crosslinked beads, which are crosslinked at 90-140 ℃ for 30 seconds-30 minutes.
The main problem of these patents is that high temperatures are used for crosslinking and the crosslinking time is too long, thus destroying the fat-soluble ingredients or carotenoids which are not stable.
Patent CN1303670A provides a powdered stable vitamin and/or carotenoid product and a preparation method thereof, which uses an alkali metal phosphate cross-linking agent to cross-link protein materials such as gelatin, casein and the like, and achieves the effect of insolubilization in water at 100 ℃ within 3 min. Although it is claimed to lower the thermal crosslinking temperature, the actual preparation process still uses the condition that the heating temperature is 55-180 ℃.
The above patent solves or partially solves the problem of water solubility of carotenoids, but uses gelatin and protein, which are obviously crosslinked to partially achieve the purpose of reducing pigment dissolution. However, the prior art does not describe how to prepare products of carotenoid preparations using other types of wall materials.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a carotenoid preparation prepared by taking non-gelatin and protein raw materials as wall materials, a preparation method and application thereof, which can effectively reduce the coloring capability of the carotenoid and simultaneously still maintain the biological activity of the carotenoid application.
The invention provides a carotenoid preparation, mixing pretreated carotenoid and pretreated gelation wall materials, and obtaining a powder or granule product through emulsification treatment and granulation; wherein:
the dosage of the gelation wall material is 60-80% of the final product weight of the carotenoid preparation;
the raw material of the pretreated gelation wall material comprises wall material and carbohydrate which are mixed according to the weight ratio of 1: 1-5;
the wall material is selected from at least two of starch, Arabic gum and cellulose derivatives;
the carbohydrate is selected from sucrose, glucose syrup, xylose, malto-oligosaccharide, fructo-oligosaccharide, solid corn syrup or mixture thereof.
With respect to the above-mentioned technical solutions, preferably, the carotenoid is selected from lutein and its fatty acid ester, zeaxanthin, lycopene, alpha-carotene, beta-carotene, canthaxanthin, astaxanthin or mixtures thereof.
For the above technical solution, preferably, the wall material is a combination of starch and cellulose derivative, and the carbohydrate is sucrose.
For the above technical solution, preferably, the carotenoid is pretreated to have a total pigment content of more than 70%.
For the technical solution mentioned above, preferably, the carotenoid in the preparation is mixed by the following raw materials: the lutein or the fatty acid ester thereof, the zeaxanthin and the beta carotene are mixed according to the weight ratio of (1-3) to (1-3).
For the above technical solution, preferably, the weight ratio of the wall material and the carbohydrate is 1: 1-3.
For the technical scheme, the wall material is preferably a mixture of starch and a cellulose derivative according to the weight ratio of 1: 1-2.
For the above technical solution, preferably, the cellulose derivative is selected from one or a mixture of several of hypromellose, methylcellulose, ethylcellulose and sodium carboxymethylcellulose, and most preferably, hypromellose.
For the above technical solution, preferably, the cellulose derivative has a viscosity of 2-15 cP.
For the above technical solution, preferably, the step of pre-treating the carotenoid further comprises an antioxidant, and the amount of the antioxidant is 5-30% of the weight of the carotenoid.
For the above technical solution, preferably, the antioxidant is selected from ascorbic acid, ascorbyl palmitate, sucrose fatty acid ester, tocopherol, fatty acid ascorbate, butyl hydroxy toluene, butyl hydroxy anisole, propyl gallic acid, tert-butyl hydroxy quinoline or a mixture thereof.
For the technical scheme, preferably, the antioxidant is ascorbic acid, ascorbyl palmitate and sucrose fatty acid ester according to the weight ratio of 2-5: 0.1-3: 0.1-3 mixing.
For the above technical solution, preferably, the zeaxanthin contains (3R,3 'R) -zeaxanthin and (3R, 3' S) -zeaxanthin in a weight ratio of 5% to 15%: 95 to 85 percent.
For the above technical solution, preferably, the dissolution rate of the pigment in water of the carotenoid preparation is less than 1%, and in a more preferred embodiment, the dissolution rate of the pigment in water of the carotenoid preparation can reach below 0.4%.
In a second aspect of the present invention, there is provided a process for preparing the carotenoid preparation, wherein the pretreated carotenoid is prepared by: mixing carotenoid and 3-5 times of 50-70% ethanol water solution, stirring at 40-50 deg.C for at least 20min, high-speed shearing for dispersing, adding antioxidant, and removing solvent at 70-80 deg.C until ethanol residue is less than 10ppm, and water content of crystal is 10-30%;
the preparation method of the pretreated gelatinized wall material comprises the following steps: mixing wall material and carbohydrate at a weight ratio of 1:1-5, making into 50-70% solid content water solution, stirring at 50-70 deg.C for dispersing, and stirring at 80-90 deg.C for 15-45 min.
The third aspect of the invention provides the application of the carotenoid preparation, including the application in the fields of food, beverage, health care products, medicines and the like.
For the above applications, preferably, the carotenoid preparation has a good application prospect in preparing products requiring a nutrient visualization effect, especially in preparing soft sweets, solid beverages and liquid beverages; and application in preparing eye gel and eye drop.
Compared with the prior art, the invention has the following beneficial effects:
1. after the product is treated by the method, the product has the characteristic of reducing pigment dissolution, the pigment dissolution rate of the product is below 1%, and the pigment dissolution rate can reach below 0.4% in a better embodiment, so the method is particularly suitable for being applied to products requiring a nutrient visualization effect.
2. After the carotenoid is pretreated, the stability is improved, and the biological activity of the carotenoid can be still maintained.
3. Organic solvent is not used in the operation process, and the preparation process is green and environment-friendly.
4. The non-gelatin and protein raw materials are used as wall materials, and the method for preparing the carotenoid preparation is enriched.
Drawings
FIG. 1 is a graph of the products prepared by the methods of example 2 and comparative example 6 according to the present invention applied to fondant, showing that a is the appearance of transparent fondant not impregnated with carotenoid prepared by the method of the present invention and B is the product B of zeaxanthin prepared by the method of comparative example 6, which dyes fondant red and transparency of fondant is decreased.
Detailed Description
The present invention is further illustrated by the following examples, but it should be understood that the scope of the present invention is not limited by the examples.
In the present invention, percentages and percentages are by mass unless otherwise specifically indicated. Unless otherwise specified, the experimental methods used are conventional methods, and the materials, reagents and the like used are commercially available.
The carotenoid preparation can be selectively added with one or more of the following components according to the conventional dosage in the field:
(1) water-soluble ingredients such as, but not limited to, glucose, lactose, malto-oligosaccharide, polyethylene glycol, sodium carboxymethylcellulose, and solid glucose syrup.
(2) Surfactants, to solve the problem of the water-insoluble fat or waxy material that the product usually floats on the water surface, increase the water dispersibility of the product. The surfactant can be exemplified by, but not limited to, tween 60, tween 80 or sucrose fatty acid ester.
(3) Binders, such as but not limited to povidone, glycerin, propylene glycol, polyglycerin fatty acid esters, soluble soybean polysaccharides, sodium carboxymethylcellulose.
(4) Suspending agents, such as but not limited to guar gum, xanthan gum, sodium alginate, hydroxypropyl methylcellulose, gellan gum, carrageenan, may be mentioned.
(5) Diluents, such as but not limited to starch, maltodextrin, calcium hydrogen phosphate.
(6) Examples of stabilizers include, but are not limited to, sodium lactate, sodium citrate, magnesium carbonate, sodium bicarbonate, microcrystalline cellulose.
(7) Glidants such as, but not limited to, silicon dioxide, corn starch, calcium silicate may be mentioned.
(8) Antioxidants, such as but not limited to vitamin E, vitamin C and derivatives thereof, may be mentioned.
(9) Examples of the acidity regulator include, but are not limited to, citric acid, lactic acid, and malic acid.
The following methods were used in the present invention to measure and evaluate the products.
The method for measuring the dissolution rate of the pigment comprises the following steps: and adding 50mL of water into 1g of the product, stirring and dissolving for 30min at 90 ℃ and 100 rpm, filtering and transferring into a volumetric flask, washing with 30mL of water once, combining filtrates, and determining the OD value of the maximum absorption wavelength after constant volume. The dissolution rate of the pigment is (OD value/product quality) multiplied by 100%.
The product accelerated stability evaluation method provided by the invention is a method provided by Chinese pharmacopoeia: the pigment content at different times is measured under the conditions of 40 ℃ and 75% RH to determine the stability, and the product stability is expressed by the pigment retention rate. Pigment retention is the ratio of product content to initial content at different times, expressed as a percentage.
The invention relates to the RELEASE degree measurement, which refers to USP (711) DISSOLUTIO, adopts Apparatus 2, rotates at 50rpm, carries out RELEASE degree experiment according to DELYED-RELEASE DOSAGE FORMS method B, selects 0.1N hydrochloric acid solution as RELEASE medium, and measures the RELEASE degree at different time.
EXAMPLE 1 Effect of the method of treating the crystals on the stability of the crystals
(1) 160g of zeaxanthin crystals and 4 times of 60% ethanol aqueous solution are mixed, stirred at 45 ℃ for 30min, then subjected to high-speed shearing dispersion at 10000 revolutions, added with 28g of ascorbic acid, 10g of ascorbyl palmitate and 10g of sucrose fatty acid ester, subjected to solvent removal at 75 ℃, and subjected to ethanol dissolution residue of 8ppm, wherein the water content of the crystals is 12.3%, and the zeaxanthin crystals A are obtained.
(2) 160g of zeaxanthin crystals and 4 times of 60% ethanol aqueous solution are mixed, stirred at 45 ℃ for 30min, then subjected to high-speed shearing dispersion at 10000 revolutions, and added with 28g of ascorbic acid and 10g of ascorbyl palmitate, the solvent is removed at 75 ℃, the ethanol residue is 55ppm, the water content of the crystals is 25%, and zeaxanthin crystals B are obtained.
(3) 160g of zeaxanthin crystals and 8 times of 80% ethanol aqueous solution are mixed, stirred at 45 ℃ for 30min, then subjected to high-speed shearing dispersion at 10000 revolutions, and then 28g of ascorbic acid, 10g of ascorbyl palmitate and 10g of sucrose fatty acid ester are added, solvent is removed at 75 ℃, ethanol residue is 155ppm, and the water content of the crystals is 32%, so that zeaxanthin crystals C are obtained.
(4) The zeaxanthin crystal D is obtained by mixing 160g of zeaxanthin crystals, 28g of ascorbic acid, 10g of ascorbyl palmitate and 10g of sucrose fatty acid ester.
(5) The zeaxanthin crystals a-D were heated at 60 ℃ and the pigment retention was measured at different times, with the results as given in table 1 below:
TABLE 1 pigment Retention at different times
In addition, zeaxanthin with different isomer ratios was selected for comparative experiments, i.e.: the zeaxanthin contains two isomers of (3R,3 'R) -zeaxanthin and (3R, 3' S) -zeaxanthin, and the weight ratio of the two isomers to the zeaxanthin is more than 80%; and the weight ratio between the two isomers (3R,3 'R) -zeaxanthin and (3R, 3' S) -zeaxanthin is 5-15%: when the content is in the range of 95-85%, the result of the step (1) is not affected.
Example 2
178g of lutein crystals and 3 times of 60% ethanol aqueous solution are mixed, stirred for 30min at 45 ℃, then sheared and dispersed at high speed of 10000 r, 20g of ascorbic acid, 1g of ascorbyl palmitate and 1g of sucrose fatty acid ester are added, solvent is removed at 75 ℃, ethanol residue is 7ppm, the water content of the crystals is 10%, and the crystals are frozen for standby at-20 ℃. Preparing water solution with solid content of 50% from 160g of corn starch, 480g of sucrose and 160g of hydroxypropyl methylcellulose (viscosity of 15cP), stirring and dispersing at 60 ℃, heating to 90 ℃, uniformly stirring for 45min, and standing at normal temperature. Mixing the gelatinized wall material and the treated xanthophyll crystal, stirring, emulsifying, and spray drying. The lutein product A is obtained, the dissolution rate of the pigment is 0.2%, and the 8-hour release rate is 3%.
Example 3
212g of beta carrot crystals and 5 times of 50% ethanol aqueous solution are mixed, stirred for 40min at 40 ℃, then subjected to high-speed shearing dispersion at 10000 r, 17g of ascorbic acid, 25.5g of ascorbyl palmitate and 25.5g of sucrose fatty acid ester are added, the solvent is removed at 70 ℃, the ethanol dissolution residue is 5ppm, the water content of the crystals is 15%, and the crystals are frozen for later use at-20 ℃. Preparing 160g of cassava starch, 480g of sucrose and 160g of hydroxypropyl methyl cellulose (the viscosity is 2.5cP) into an aqueous solution with the solid content of 50%, stirring and dispersing at 50 ℃, heating to 80 ℃, uniformly stirring for 15min, and standing at normal temperature. Mixing the gelatinized wall material and the treated xanthophyll crystal, stirring, emulsifying, and spray drying. The beta carrot crystal product A is obtained, the dissolution rate of the pigment is 0.4%, and the 8-hour release rate is 5.2%.
Example 4
Mixing 81g of beta carrot crystal, 162g of lutein ester crystal, 81g of zeaxanthin crystal and 4 times of 70% ethanol aqueous solution, stirring at 50 ℃ for 55min, performing high-speed shearing dispersion at 10000 revolutions, adding 73g of ascorbic acid, 1.5g of ascorbyl palmitate and 1.5g of sucrose fatty acid ester, removing the solvent at 80 ℃, removing 3ppm of ethanol residue, ensuring that the water content of the crystal is 30%, and freezing at-20 ℃ for later use. 100g of potato starch, 300g of sucrose and 200g of hydroxypropyl methyl cellulose (viscosity 5cP) are prepared into an aqueous solution with solid content of 50%, the aqueous solution is stirred and dispersed at 70 ℃, the temperature is raised to 82 ℃, the uniform stirring is carried out for 30min, and the aqueous solution is placed at the normal temperature. Mixing the gelatinized wall material and the treated xanthophyll crystal, stirring, emulsifying, and spray drying. The lutein ester, zeaxanthin and beta carrot product A with the ratio of 2:1:1 are obtained, the pigment dissolution rate is 0.26 percent, and the 8-hour release rate is 6.1 percent.
Comparative example 5
Mixing 200g of lutein crystal with 3 times of 60% ethanol aqueous solution, stirring at 45 ℃ for 30min, performing high-speed shearing dispersion at 10000 revolutions, adding 20g of ascorbic acid, 1g of ascorbyl palmitate and 1g of sucrose fatty acid ester, removing solvent at 75 ℃, dissolving ethanol residue by 7ppm, ensuring that the water content of the crystal is 10%, and freezing at-20 ℃ for later use. 583g of sodium octenyl succinate starch and 195g of glucose are prepared into an aqueous solution with solid content of 50 percent, and after stirring and dispersing at 60 ℃, the temperature is raised to 90 ℃, and stirring is carried out at constant speed for 35 min. Cooling to 60 deg.C, and stirring for 100 min. Mixing the gelatinized wall material and the treated xanthophyll crystal, stirring, emulsifying, and spray drying. The lutein product A is obtained, the dissolution rate of the pigment is 3.1 percent, and the 8-hour release rate is 101.6 percent. The release rates at different times are shown in table 2 below:
TABLE 2 Release degree at different times
Time | Degree of release | Time | Degree of release |
10min | 10.0% | 3h | 101.6% |
20min | 16.0% | 4h | 103.3% |
30min | 30.5% | 6h | 101.6% |
1h | 40.2% | 8h | 101.6% |
2h | 89.4% |
According to the technical scheme of the comparative example 5, through the combination of the octenyl sodium starch succinate and the glucose, the release degree of the obtained product is superior to that of the technical schemes of the examples 1 to 4, but the dissolution rate is poor, and according to the analysis of effect data, the pigment dissolution rate of the product obtained according to the technical scheme of the comparative example 5 is 3.1% which is 8-15 times of the pigment dissolution rate (0.2-0.4%) of the products obtained in the examples 1 to 4, so that the technical scheme of the application is far superior to that of the prior art in the aspect of improving the pigment dissolution rate of the product, and has extremely remarkable effect improvement.
Comparative example 6
178g of zeaxanthin crystals and 3 times of 60% ethanol aqueous solution are mixed, stirred at 45 ℃ for 30min, then subjected to high-speed shearing dispersion at 10000 revolutions, added with 20g of ascorbic acid, 1g of ascorbyl palmitate and 1g of sucrose fatty acid ester, subjected to solvent removal at 75 ℃, 7ppm of ethanol residues and 12.8% of water content of the crystals, and frozen at-20 ℃ for later use. Preparing 160g of cassava starch, 480g of sucrose and 160g of hydroxypropyl methyl cellulose (viscosity is 10cP) into an aqueous solution with solid content of 50%, stirring and dissolving, adding the zeaxanthin crystals, stirring, emulsifying, and spray-drying. The pigment dissolution rate of the zeaxanthin product B is 67.7 percent. The 8h release degree is 99.1%.
The contrast shows that the chroma of the product is improved and the slow release effect is deteriorated by the wall material which is not subjected to gelation treatment.
Comparative example 7
Adding 200g of lutein crystal into 20g of ascorbic acid, 1g of ascorbyl palmitate and 1g of sucrose fatty acid ester, mixing, preparing a 50% solid content aqueous solution from 160g of cassava starch, 480g of sucrose and 160g of hydroxypropyl methyl cellulose (viscosity is 10cP), stirring and dispersing at 50 ℃, heating to 80 ℃, uniformly stirring for 15min, and standing at normal temperature. Mixing the gelatinized wall material and the lutein crystal, stirring, emulsifying, and spray drying. The lutein product B with the pigment dissolution rate of 30.2 percent is obtained. The 8h release degree is 95.8%.
As can be seen by comparison, the chroma and the release degree of the product are both deteriorated without the pretreatment of the crystals.
Comparative example 8
200g of lutein ester crystals and 3 times of 60% ethanol aqueous solution are mixed, stirred for 30min at 45 ℃, then subjected to high-speed shearing dispersion at 10000 revolutions, added with 20g of ascorbic acid, 1g of ascorbyl palmitate and 1g of sucrose fatty acid ester, subjected to solvent removal at 75 ℃, and subjected to ethanol residue removal of 7ppm, wherein the water content of the crystals is 10%, and then frozen at-20 ℃ for later use. The gelling wall material compositions in the table are respectively added, and the product effect is shown in the following table 3 after the treatment according to the gelling method in the example 2:
TABLE 3 comparison of dissolution effects using different gelling wall materials
In contrast, the combination of a wall material (corn starch or hydroxypropylmethyl cellulose) and a carbohydrate alone is not effective. And the formula does not contain carbohydrate, so the effect is poor. The effect of the formula in which corn starch and Arabic gum are used as wall materials and are gelatinized together with sucrose is also poor. The experimental group using hydroxypropylmethylcellulose having a high viscosity as a wall material also did not achieve the expected effect.
Effect example 9
Lutein, zeaxanthin and beta-carotene were prepared according to the method of patent 201711456450.1 at a weight ratio of 1:1:1 to obtain composite product 1, and lutein, zeaxanthin and beta-carotene were prepared using the method of example 2 at a weight ratio of 1:1:1 to obtain composite product 2, the comparative parameters for the two products are as follows in table 4:
TABLE 4 two product comparison parameters
Bulk density | 6 months retention accelerated at 40 ℃ | Dissolution rate of pigment | Degree of release of 8h | |
Composite product 1 | 0.68 | 98.7% | 68.2% | 102.3 |
Composite product 2 | 0.66 | 98.9% | 0.32% | 5.3% |
Effect example 10: evaluation of fondant applications
Weighing 8g of gelatin, 44g of white granulated sugar and 55g of glucose syrup, adding water with 20% of solid matters, stirring for dissolving, decocting at 120 ℃ until the solid matters are about 85%, and adjusting the pH value to 3-4; solution I was obtained.
The lutein product A obtained by the method of example 2 or the zeaxanthin product B20g obtained by the method of example 6 are added into the solution I and stirred uniformly. Keeping the temperature at 90 ℃ for 40 min. And (5) injection molding and drying. The appearance is shown in picture 1. It can be seen that the lutein product A has no staining phenomenon in the soft sweets, is completely stored in the soft sweets, and realizes the effect of nutrition visualization. The zeaxanthin product B stained the fondant red and the transparency of the fondant was reduced.
Effect example 11
0.03 part of the lutein product A prepared by the method in the embodiment 2 and 0.02 part of the lutein ester product B prepared by the method in the embodiment 8 are respectively mixed with proper amount of taurine, 0.002 part of vitamin A, 0.3 part of hyaluronic acid, 12 parts of glycerol, 9 parts of sodium chloride, 0.2 part of methyl paraben, 0.1 part of menthol and proper amount of water for injection, and the lutein eye drops are obtained by filtering, filling and sterilizing. The effect of the eye drops was evaluated as shown in table 5:
table 5: evaluation of application Effect of eye drops
Solid beverage numbering | Eye drop color | Eye drops particle size |
Xanthophyll product A | Transparent and colorless | 250nm |
Lutein ester product B | Light yellow | 800nm |
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and those skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (14)
1. A carotenoid preparation is characterized in that a powder or granule product is obtained by mixing pretreated carotenoid and pretreated gelation wall material, emulsifying and granulating; wherein:
the dosage of the gelation wall material is 60-80% of the final product weight of the carotenoid preparation;
the raw material of the pretreated gelation wall material comprises wall material and carbohydrate which are mixed according to the weight ratio of 1: 1-5;
the wall material is selected from at least two of starch, Arabic gum and cellulose derivatives;
the carbohydrate is at least one selected from sucrose, glucose syrup, xylose, malto-oligosaccharide, fructo-oligosaccharide and solid corn syrup.
2. The carotenoid formulation according to claim 1, wherein the carotenoid is at least one selected from the group consisting of lutein and fatty acid esters thereof, zeaxanthin, lycopene, alpha-carotene, beta-carotene, canthaxanthin, and astaxanthin.
3. The carotenoid formulation of claim 1 wherein the carotenoid has a total pigment content of greater than 70% after pretreatment.
4. The carotenoid formulation according to claim 1, wherein the carotenoid is mixed from the following raw materials: the lutein or the fatty acid ester thereof, the zeaxanthin and the beta carotene are mixed according to the weight ratio of (1-3) to (1-3).
5. The carotenoid preparation according to claim 1, wherein the wall material is a mixture of starch and cellulose derivative in a weight ratio of 1: 1-2.
6. The carotenoid formulation of claim 1 wherein the cellulose derivative is selected from at least one of hypromellose, methylcellulose, ethylcellulose, and sodium carboxymethylcellulose.
7. The carotenoid formulation according to claim 6, characterized in that the viscosity of the cellulose derivative is 2-15 cP.
8. The carotenoid formulation of claim 1 wherein the step of pre-treating the carotenoid further comprises an antioxidant in an amount of 5-30% by weight of the carotenoid.
9. The carotenoid formulation according to claim 8, wherein the antioxidant is at least one selected from ascorbic acid, ascorbyl palmitate, sucrose fatty acid ester, tocopherol, fatty acid ascorbate, butyl hydroxytoluene, butyl hydroxyanisole, propyl gallic acid, and tert-butyl hydroxyquinoline.
10. The carotenoid formulation according to claim 9, wherein the antioxidant is ascorbic acid, ascorbyl palmitate or sucrose fatty acid ester in a weight ratio of 2-5: 0.1-3: 0.1-3 mixing.
11. The carotenoid formulation according to claim 1, wherein the pigment dissolution in water is less than 1%.
12. The method of producing a carotenoid formulation according to claim 1, wherein the pretreated carotenoid is produced by: mixing carotenoid and 3-5 times of 50-70% ethanol water solution, stirring at 40-50 deg.C for at least 20min, high-speed shearing for dispersing, adding antioxidant, and removing solvent at 70-80 deg.C until ethanol residue is less than 10ppm, and water content of crystal is 10-30%;
the preparation method of the pretreated gelatinized wall material comprises the following steps: mixing wall material and carbohydrate at a weight ratio of 1:1-5, making into 50-70% solid content water solution, stirring at 50-70 deg.C for dispersing, and stirring at 80-90 deg.C for 15-45 min.
13. Use of the carotenoid preparation according to claim 1 in the fields of food, beverage, health product and medicine.
14. Use according to claim 13, characterized in that: the carotenoid preparation is applied to the preparation of products requiring the visual effect of nutrients, soft sweets, solid beverages and liquid beverages, or the preparation of eye gels and eye drops.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111633948.7A CN114276285B (en) | 2021-12-28 | 2021-12-28 | Carotenoid preparation, preparation method and application thereof |
JP2023554278A JP2024509226A (en) | 2021-12-28 | 2022-12-28 | Carotenoid preparations, preparation methods, and their applications |
PCT/CN2022/142679 WO2023125626A1 (en) | 2021-12-28 | 2022-12-28 | Carotenoid preparations, preparation methods, and application thereof |
EP22914878.8A EP4259603A4 (en) | 2021-12-28 | 2022-12-28 | Carotenoid preparations, preparation methods, and application thereof |
US18/357,149 US20240016741A1 (en) | 2021-12-28 | 2023-07-23 | Carotenoid preparations, preparation methods, and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111633948.7A CN114276285B (en) | 2021-12-28 | 2021-12-28 | Carotenoid preparation, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114276285A true CN114276285A (en) | 2022-04-05 |
CN114276285B CN114276285B (en) | 2024-06-04 |
Family
ID=80877596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111633948.7A Active CN114276285B (en) | 2021-12-28 | 2021-12-28 | Carotenoid preparation, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114276285B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023125626A1 (en) * | 2021-12-28 | 2023-07-06 | Innobio Corporation Limited | Carotenoid preparations, preparation methods, and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522743A (en) * | 1981-05-15 | 1985-06-11 | Basf Aktiengesellschaft | Preparation of finely divided pulverulent carotinoid and retinoid compositions |
US5364563A (en) * | 1989-07-25 | 1994-11-15 | Hoffmann-La Roche Inc. | Powdered aqueous carotenoid dispersions |
CN101888786A (en) * | 2007-12-05 | 2010-11-17 | 帝斯曼知识产权资产管理有限公司 | Pulverous formulation of a fat-soluble active ingredient |
CN103406079A (en) * | 2013-06-28 | 2013-11-27 | 大连医诺生物有限公司 | Method for preparing cold water dispersing type carotenoid micro-capsule powder without using organic solvent |
CN104883906A (en) * | 2012-08-26 | 2015-09-02 | 利库德有限公司 | Hue-controlled beta-carotene formulations |
CN108185424A (en) * | 2017-12-28 | 2018-06-22 | 大连医诺生物股份有限公司 | Carotenoid microparticle formulation and preparation method thereof |
CN112056558A (en) * | 2020-09-21 | 2020-12-11 | 华南农业大学 | Oil-in-water carotene microemulsion and preparation method thereof |
-
2021
- 2021-12-28 CN CN202111633948.7A patent/CN114276285B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522743A (en) * | 1981-05-15 | 1985-06-11 | Basf Aktiengesellschaft | Preparation of finely divided pulverulent carotinoid and retinoid compositions |
US5364563A (en) * | 1989-07-25 | 1994-11-15 | Hoffmann-La Roche Inc. | Powdered aqueous carotenoid dispersions |
CN101888786A (en) * | 2007-12-05 | 2010-11-17 | 帝斯曼知识产权资产管理有限公司 | Pulverous formulation of a fat-soluble active ingredient |
CN104883906A (en) * | 2012-08-26 | 2015-09-02 | 利库德有限公司 | Hue-controlled beta-carotene formulations |
CN103406079A (en) * | 2013-06-28 | 2013-11-27 | 大连医诺生物有限公司 | Method for preparing cold water dispersing type carotenoid micro-capsule powder without using organic solvent |
CN108185424A (en) * | 2017-12-28 | 2018-06-22 | 大连医诺生物股份有限公司 | Carotenoid microparticle formulation and preparation method thereof |
CN112056558A (en) * | 2020-09-21 | 2020-12-11 | 华南农业大学 | Oil-in-water carotene microemulsion and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
PRABHJOT KAUR等: "Encapsulation of carotenoids with sucrose by co-crystallization: Physicochemical properties, characterization and thermal stability of pigments", LWT - FOOD SCIENCE AND TECHNOLOGY, no. 140, pages 110810 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023125626A1 (en) * | 2021-12-28 | 2023-07-06 | Innobio Corporation Limited | Carotenoid preparations, preparation methods, and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114276285B (en) | 2024-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101177540B (en) | Method for preparing lutein water-soluble dry powder | |
JP4988081B2 (en) | Stable lycopene powder formulations, stable lycopene aqueous dispersions, their preparation, their use and nutritional supplements containing them, animal feed, food, and pharmaceuticals and cosmetics | |
JP4195113B2 (en) | Method for producing powdery carotenoid preparation dispersible in cold water, preparation of this kind and use thereof | |
US5827539A (en) | Dry carotenoid-oil powder and process for making same | |
US20210322371A1 (en) | Nanosized carotenoid cyclodextrin complexes | |
US3655406A (en) | Carotenoid compositions | |
WO2020248295A1 (en) | Plant-based soft capsule and preparation method therefor and uses thereof | |
CN102578346A (en) | Lutein ester soft sweet and preparation method thereof | |
CN101507704A (en) | Lutein solid dispersoid and preparation method thereof | |
NO320106B1 (en) | Stable aqueous dispersions and stable, water dispersible dry powder of xanthophyll compounds, as well as processes for their preparation and use. | |
US20200029596A1 (en) | Fat-soluble nutrient microcapsule and preparation method thereof | |
JPH0366615A (en) | Manufacture of new colloid dispersion carotinoid preparation | |
CN108208815A (en) | Blueberry and the double-colored composite sheet of lutein ester and preparation method thereof | |
JP2004514419A (en) | Method for producing water-dispersible compound containing carotenoid | |
DE60223569T2 (en) | ZEACAROTENE PAINTING FOR FOOD OR PHARMACEUTICALS | |
CN108148444A (en) | A kind of high-content beta carotene microcapsules for being used for coloring and preparation method thereof | |
CN113826905B (en) | Photosensitive-resistant vitamin K2 microcapsule preparation and preparation method thereof | |
CN114276285B (en) | Carotenoid preparation, preparation method and application thereof | |
CN106723031A (en) | Matrimony vine zeaxanthin, lutein, the preparation method of vitamin E soft capsule | |
CN102475696A (en) | Water-soluble lutein and preparation process thereof | |
CN114287625B (en) | Carotenoid preparation and application thereof | |
CN113925157B (en) | Beta-carotene emulsion and preparation method thereof | |
CN109123309A (en) | A kind of astaxanthin-containing can alleviate visual fatigue but also the solid beverage for improving eyesight and preparation method thereof | |
CN105072926B (en) | It is suitble to the lutein composition of infant food preparation | |
CN112515088B (en) | Water-dispersible lutein ester preparation and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |